BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20470476)

  • 1. [Cutaneous adverse reaction to carbamazepine: unusual presentation].
    Duarte AF; Baudrier T; Mota A; Azevedo F
    Acta Med Port; 2010; 23(2):267-72. PubMed ID: 20470476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
    Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
    J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous reaction to carbamazepine.
    Matthews R; Philip J
    Br Dent J; 2003 Feb; 194(3):121. PubMed ID: 12598877
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute generalised exanthematous pustulosis and toxic epidermal necrolysis induced by carbamazepine.
    Goh TK; Pang SM; Thirumoorthy T; Goh SG
    Singapore Med J; 2008 Jun; 49(6):507-10. PubMed ID: 18581028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe carbamazepine-induced cutaneous reaction in the treatment of post-herpetic neuralgia. Case report.
    Garcia JB; Ferro LS; Carvalho AB; da Rocha RM; de Souza LM
    Rev Bras Anestesiol; 2010; 60(4):429-37. PubMed ID: 20659616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palmoplantar eruption associated with etretinate therapy.
    David M; Ginzburg A; Hodak E; Feuerman EJ
    Acta Derm Venereol; 1986; 66(1):87-9. PubMed ID: 2424229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapy.
    Yang CH; Lin WC; Chuang CK; Chang YC; Pang ST; Lin YC; Kuo TT; Hsieh JJ; Chang JW
    Br J Dermatol; 2008 Mar; 158(3):592-6. PubMed ID: 18070211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Palmoplantar cutaneous reaction to sorafenib].
    Echeverría B; Llombart B; Botella-Estrada R; Guillén C
    Actas Dermosifiliogr; 2009 Oct; 100(8):736-7. PubMed ID: 19775561
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor.
    Autier J; Escudier B; Wechsler J; Spatz A; Robert C
    Arch Dermatol; 2008 Jul; 144(7):886-92. PubMed ID: 18645140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hand-foot syndrome.
    Pike K
    Oncol Nurs Forum; 2001; 28(10):1519-20. PubMed ID: 11759299
    [No Abstract]   [Full Text] [Related]  

  • 11. [A man with blisters on hand and feet].
    Gelderblom AJ; van der Rhee JI; Ouwerkerk J
    Ned Tijdschr Geneeskd; 2011; 155(45):A3994. PubMed ID: 22085574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin problems associated with pegylated liposomal doxorubicin-more than palmoplantar erythrodysesthesia syndrome.
    Mangana J; Zipser MC; Conrad C; Oberholzer PA; Cozzio A; Knuth A; French LE; Dummer R
    Eur J Dermatol; 2008; 18(5):566-70. PubMed ID: 18693162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fixed pigmented erythema related to the oral administration of carbamazepine: report of one case].
    Alvarez VJ; Picón JE; Morales AR; Goncalves ET; Luna JR
    Invest Clin; 2006 Mar; 47(1):65-9. PubMed ID: 16562645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of toxic epidermal necrolysis with intravenous immunoglobulin.
    Sidwell RU; Swift S; Yan CL; Porter W; Thompson EM; Clark JA; Bunker CB
    Int J Clin Pract; 2003 Sep; 57(7):643-5. PubMed ID: 14529073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients.
    Kashiwagi M; Aihara M; Takahashi Y; Yamazaki E; Yamane Y; Song Y; Muramatsu M; Ikezawa Z
    J Dermatol; 2008 Oct; 35(10):683-5. PubMed ID: 19017052
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cutaneous pseudolymphoma caused by carbamazepine].
    d'Incan M; Mouillet ML; Roger H; Ferrier MC; Buono JP; Déchelotte P; Bignon YJ; Souteyrand P
    Ann Dermatol Venereol; 1998 Jan; 125(1):52-5. PubMed ID: 9747211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Generalized acute exanthematous pustulosis caused by carbamazepine].
    Lachgar T
    Allerg Immunol (Paris); 1999 May; 31(5):151-2. PubMed ID: 10399524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carbamazepine intolerance mimicking infectious mononucleosis: apropos of 3 cases].
    Merle De Boever C; Sotto A; Guillot B; Jourdan J
    Therapie; 1999; 54(4):489-91. PubMed ID: 10667117
    [No Abstract]   [Full Text] [Related]  

  • 19. Search for evidence-based approaches for the prevention and palliation of hand-foot skin reaction (HFSR) caused by the multikinase inhibitors (MKIs).
    Anderson R; Jatoi A; Robert C; Wood LS; Keating KN; Lacouture ME
    Oncologist; 2009 Mar; 14(3):291-302. PubMed ID: 19276294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrence of palmoplantar psoriasiform eruptions and hair loss during carbamazepine treatment.
    Oh SH; Kim DS; Kwon YS; Lee JH; Lee KH
    Acta Derm Venereol; 2008; 88(5):532-3. PubMed ID: 18779906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.